Europe — EMA
Ondansetron Hexal (Ondansetron Hydrochloride Dihydrate)
GNH USA supplies Ondansetron Hexal (Ondansetron), a 5‑HT3 receptor antagonist for prevention of chemotherapy, radiotherapy and postoperative nausea
Request sourcing
What is Ondansetron Hydrochloride Dihydrate?
Ondansetron, the active ingredient in Ondansetron Hexal, is a 5-HT3 receptor antagonist presented as an intravenous solution for intravenous use. It prevents nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative settings.
GNH USA supplies Ondansetron Hexal as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide.
What is Ondansetron Hydrochloride Dihydrate used for?
Ondansetron is a 5‑HT3 receptor antagonist used to control nausea and vomiting in several clinical contexts.
- Chemotherapy-induced nausea and vomiting: prevents and treats nausea and vomiting in patients receiving cytotoxic chemotherapy. - Radiotherapy-induced nausea and vomiting: reduces nausea and vomiting associated with radiation therapy. - Postoperative nausea and vomiting: helps prevent nausea and vomiting after surgical procedures.
What are the side effects of Ondansetron Hydrochloride Dihydrate?
Ondansetron may cause a range of adverse reactions, varying from mild to serious.
Common Side Effects: - Headache: mild to moderate pain in the head. - Constipation: reduced bowel movements or hard stools. - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: feeling unusually tired or weak. - Diarrhoea: loose, watery stools. - Injection site reactions: pain, erythema, or swelling at the IV site.
Serious or Rare Side Effects: - QT prolongation: abnormal heart rhythm that may lead to arrhythmia. - Severe allergic reactions: anaphylaxis, rash, or swelling. - Serotonin syndrome: potentially life‑threatening condition when combined with other serotonergic agents. - Cardiac arrhythmias: irregular heartbeats beyond QT changes. - Severe hypotension: marked drop in blood pressure.
What precautions apply to Ondansetron Hydrochloride Dihydrate?
Before initiating therapy, clinicians should consider several safety aspects.
- Assess cardiac risk: monitor QT interval in patients with known cardiac disease or electrolyte imbalance. - Avoid in patients with known hypersensitivity: do not use if the patient has reacted to ondansetron or other 5‑HT3 antagonists. - Use caution in hepatic impairment: dose adjustment may be required for reduced liver function. - Consider pregnancy status: evaluate risk versus benefit as safety data are limited. - Monitor for serotonin syndrome: watch for signs when combined with serotonergic drugs. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Ondansetron Hydrochloride Dihydrate interact with?
Ondansetron can interact with other medicines, requiring attention to the level of risk.
Major Interactions (Avoid): - Concurrent use with other QT‑prolonging drugs: may increase risk of cardiac arrhythmia. - Combination with apomorphine: can cause severe hypotension and loss of consciousness. - Use with serotonergic agents (e.g., SSRIs, MAOIs): may increase risk of serotonin syndrome.
Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., ketoconazole): may increase ondansetron plasma levels. - CYP2D6 inhibitors (e.g., fluoxetine): may modestly increase exposure. - Ritonavir: may raise ondansetron concentrations; monitor for side effects.
